Prior Auth Required

0342T - Therapeutic apheresis with selective HDL delipidation and plasma reinfusion

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceTherapeutic apheresis with selective HDL delipidation and plasma reinfusion
Procedure / Service Description

Transcatheter renal sympathetic denervation, percutaneous approach including arterial - and germline DNA, reported as absence or presence of MRD, with disease-burden correlation, 0340U if appropriate 0342T Therapeutic apheresis with selective HDL delipidation and plasma reinfusion Oncology (pancreatic cancer), multiplex immunoassay of C5, C4, cystatin C, factor B, osteoprotegerin (OPG), gelsolin, IGFBP3, CA125 and multiplex electrochemiluminescent

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.